% | $
Quotes you view appear here for quick access.

Zimmer Biomet Holdings, Inc. Message Board

  • richards1505 richards1505 Jul 22, 2008 5:13 PM Flag

    revised guidance

    "The Company is revising its guidance and expects full-year 2008 sales growth to be in a range of 8.5% to 9.0% over the prior year, which reflects constant currency growth of 4.5% to 5.0%. This compares with prior guidance of 10% to 11% reported and 6% to 7% constant currency growth over prior year. The adjustment to sales guidance includes a projected loss of $20 to $30 million in hip product sales pertaining to the Durom Cup in the U.S., weakness in U.S. Dental revenues and slower than anticipated uptake on certain new products. Adjusted diluted earnings per share for the full year are expected to be in a range of $4.05 to $4.10, as compared to prior guidance of $4.20 to $4.25. Revised earnings guidance gives effect to the reduction in sales from prior guidance as well as an increase in operating expenses associated with the global implementation of the Company's enhanced compliance program..."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
127.57-0.44(-0.34%)10:35 AMEDT